Коллектив авторов - Долгая жизнь с муковисцидозом

Neglia JP, FitzSimmons SC, Maisonneuve P, et al. The risk of cancer among patients with cystic fibrosis. Cystic Fibrosis and Cancer Study Group. N Engl J Med 1995; 332: 494-9.

Maisonneuve P, FitzSimmons SC, Neglia JP, et al. Cancer risk in nontransplanted and transplanted cystic fibrosis patients: a 10-year study. J Natl Cancer Inst 2003; 95: 381-7

Johannesson M, Askling J, Montgomery SM, et al. Cancer risk among patients with cystic fibrosis and their first-degree relatives. Int J Cancer 2009; 125: 2953-6.

Ploessl C, Pettit RS, Donaldson J. Prevalence of depression and antidepressant therapy use in a pediatric cystic fibrosis population. Ann Pharmacother 2014; 48: 488-93.

Riekert KA, Bartlett SJ, Boyle MP, et al. The association between depression, lung function, and health-related quality of life among adults with cystic fibrosis. Chest 2007; 132: 231-7.

DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: metaanalysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000; 160: 2101-7.

Ploessl C, Pettit RS, Donaldson J. Prevalence of depression and antidepressant therapy use in a pediatric cystic fibrosis population. Ann Pharmacother 2014; 48: 488-93.

Riekert KA, Bartlett SJ, Boyle MP, et al. The association between depression, lung function, and health-related quality of life among adults with cystic fibrosis. Chest 2007; 132: 231-7.

LiouTG, Adler FR, Huang D. Use of lung transplantation survival models to refine patient selection in cystic fibrosis. Am J Respir Crit Care Med 2005; 171: 1053-9.

Mayer-Hamblett N, Rosenfeld M, Emerson J, et al. Developing cystic fibrosis lung transplant referral criteria using predictors of 2-year mortality. Am J Respir Crit Care Med 2002; 166: 1550-5.

Kerem E, Reisman J, Corey M, et al. Prediction of mortality in patients with cystic fibrosis. N Engl J Med 1992; 326: 1187-91.

George PM, Banya W, Pareek N, et al. Improved survival at low lung function in cystic fibrosis: cohort study from 1990 to 2007 BMJ 2011; 342: d1008

Hodson ME, Simmonds NJ, Warwick WJ, et al. An international/ multicentre report on patients with cystic fibrosis (CF) over the age of 40 years. J Cyst Fibros 2008; 7: 537-42.

Simmonds NJ, Cullinan R Hodson ME. Growing old with cystic fibrosis – the characteristics of long-term survivors of cystic fibrosis. Respir Med 2009; 103: 629-35.

AndrieuxA, HarambatJ, BuiS, et al. Renal impairment in children with cystic fibrosis. J Cyst Fibros 2010;9:263-8.

Catherinot E, Roux A-L, Vibet M-A, et al. Mycobacterium avium and Mycobacterium abscessus complex target distinct cystic fibrosis patient subpopulations. J Cyst Fibros 2013; 12: 74–80.

Plant BJ,GossCH, Plant WD, et al. Management of comorbidities in older patients with cystic fibrosis. Lancet Resp Med 2013; 1: 164-74.

Cystic Fibrosis Foundation. Patient registry annual data report 2011. Bethesda: Cystic Fibrosis Foundation; 2011. http://www.cff.org/UploadedFiles/research/ClinicalResearch/2011-Patient-Registry.pdf

Tonelli MR, Aitken ML. Pregnancy in cystic fibrosis. Curr Opin Pulm Med 2007; 13: 537^10.

Schechter MS, Quittner AL, Konstan MW, et al. Long-term effects of pregnancy and motherhood on disease outcomes of women with cystic fibrosis. Ann Am Thorac Soc2013; 10:213-19.

GyiKM, HodsonME,YacoubMY. Pregnancy in cystic fibrosis lung transplant recipients: case series and review. J Cyst Fibros 2006; 5: 171-5.

Bullough B. Poverty, ethnic identity and preventive health care. J Health Soc Behav 1972: 347-59.

Duncan GJ, Brooks-Gunn J. Family poverty, welfare reform, and child development. Child Dev 2000; 71: 188-96.

Wagstaff A. Poverty and health sector inequalities. Bull World Health Organ 2002; 80: 97-105.

Cystic Fibrosis Foundation. Patient registry annual data report 2011. Bethesda: Cystic Fibrosis Foundation; 2011. http://www.cff.org/UploadedFiles/research/ClinicalResearch/2011-Patient-Registry.pdf

Targett K, Bourke S, Nash E, et al. Employment in adults with cystic fibrosis. Occup Med 2014; 64: 87–94.

Boyle MP, Sabadosa KA, Quinton HB, et al. Key findings of the US Cystic Fibrosis Foundation's clinical practice benchmarking project. BMJ Qual Saf 2014; 23 (Suppl 1): i15-i22.

Boyce MB, Browne JP, Greenhalgh J. The experiences of professionals with using information from patient-reported outcome measures to improve the quality of healthcare: a systematic review of qualitative research. BMJ Qual Saf 2014; 23: 508-18.

Smyth AR, Bell SC, Bojcin S, et al. European Cystic Fibrosis Society Standards of Care: best practice guidelines. J Cyst Fibros 2014; 13: S23-S42.

Conway S, Balfour-Lynn IM, De Rijcke K, et al. European Cystic Fibrosis Society Standards of Care: framework for the cystic fibrosis centre. J Cyst Fibros 2014; 13: S3-S22.

Stern M, Bertrand DP, Bignamini E, et al. European Cystic Fibrosis Society Standards of Care: quality management in cystic fibrosis. J Cyst Fibros 2014; 13: S43-S59.

Klimes Ji, Dolezal T, Kubackova K, et al. Health-economic aspects of cystic fibrosis screening and therapy. In: Mall MA, Elborn JS, eds. Cystic fibrosis. Eur Resp Monogr 2014; 64: 304–319.

Buzzetti R, Salvatore D, Baldo E, et al. An overview of international literature from cystic fibrosis registries: 1. Mortality and survival studies in cystic fibrosis. J Cyst Fibros 2009; 8: 229-37.

Flume PA, Strange C, Ye X, etal. Pneumothorax in cystic fibrosis. Chest 2005; 128:720-8.

Flume PA, Strange C, Ye X, etal. Pneumothorax in cystic fibrosis. Chest 2005; 128:720-8.

Flume PA, Strange C, Ye X, etal. Pneumothorax in cystic fibrosis. Chest 2005; 128:720-8.

Phillips GD, Trotman-Dickenson B, Hodson ME, et al. Role of CT in the management of pneumothorax in patients with complex cystic lung disease. Chest 1997; 112:275-8.

Flume PA, Mogayzel PJ Jr, Robinson KA, et al. Cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax. Am J Respir Crit Care Med 2010; 182: 298–306.

Flume PA, Mogayzel PJ Jr, Robinson KA, et al. Cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax. Am J Respir Crit Care Med 2010; 182: 298–306.

Amin R, Noone PG, Ratjen F. Chemical pleurodesis versus surgical intervention for persistent and recurrent pneumothoraces in cystic fibrosis. Cochrane Database Syst Rev 2012; 12: CD007481.